Affiliations

• ¹ Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, 90033, California, USA.
• ² Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
• ³ Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK.
• ⁴ QIMR Berghofer Medical Research Institute, Brisbane, 4029, Queensland, Australia.
• ⁵ Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK.
• ⁶ Medical College, Xiamen University, Xiamen, 361102, China.
• ⁷ Department of Medical Oncology, The Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, 02215, Massachusetts, USA.
• ⁸ Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, 00029 HUS, Finland.
• ⁹ Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, M5G 1X5, Ontario, Canada.
• ¹⁰ Department of Molecular Genetics, University of Toronto, Toronto, M5S 1A8, Ontario, Canada.
• ¹¹ Department of Epidemiology, Genetic Epidemiology Research Institute, School of Medicine, University of California Irvine, Irvine, 92697, California, USA.
• ¹² Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
• ¹³ University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA.
• ¹⁴ Department of Oncology, Karolinska University Hospital, Stockholm, 171 77, Sweden.
• ¹⁵ Cancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, 08903, New Jersey, USA.
• ¹⁶ Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, 20141, Italy.
• ¹⁷ Department of Pathology, Landspitali University Hospital and BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, 600169-2039, Iceland.
• ¹⁸ Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, 91054, Germany.
• ¹⁹ Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, E-28029, Spain.
• ²⁰ Centro de Investigación en Red de Enfermedades Raras, Valencia, 28029, Spain.
• ²¹ Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, 27710, North Carolina, USA.
• ²² Department of Surgery, Gynecology Service, Memorial Sloan-Kettering Cancer Center, New York, 10065, USA.
• ²³ Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, 5021, Norway.
• ²⁴ Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, Bergen, N-5020, Norway.
• ²⁵ Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, FIN-00029, Finland.
• ²⁶ Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, 37203, Tennessee, USA.
• ²⁷ International Epidemiology Institute, Rockville, 20850, Maryland, USA.
• ²⁸ Gynaecology Research Unit, Hannover Medical School, Hannover, D-30625, Germany.
• ²⁹ Department of Clinical Genetics, Vejle Hospital, Vejle, 7100, Denmark.
• ³⁰ Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, 2200, Denmark.
• ³¹ Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, 2730, Denmark.
• ³² Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, 2730, Denmark.
• ³³ Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, N-0310, Norway.
• ³⁴ K.G. Jebsen Center for Breast Cancer Research, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, N-0310, Norway.
• ³⁵ Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, D-70376, Germany.
• ³⁶ University of Tübingen, Tübingen, 72074, Germany.
• ³⁷ German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
• ³⁸ International Agency for Research on Cancer, Lyon, 69008, France.
• ³⁹ Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, 69121, Germany.
• ⁴⁰ Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, 3004, Victoria, Australia.
• ⁴¹ Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Girona, 08908, Spain.
• ⁴² Department of Surgery, National University Health System, Singapore, 119077, Singapore.
• ⁴³ Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
• ⁴⁴ Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, 69120, Germany.
• ⁴⁵ Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, 00029 HUS, Finland.
• ⁴⁶ Department of Pathology, Helsinki University Central Hospital, Helsinki, 00029, Finland.
• ⁴⁷ Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, 84112, Utah, USA.
• ⁴⁸ Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, 28040, Spain.
• ⁴⁹ Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, 3002, Victoria, Australia.
• ⁵⁰ Division of Cancer Prevention and Population Sciences, Cancer Pathology & Prevention, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, 14263, New York, USA.
• ⁵¹ Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, 69121, Germany.
• ⁵² University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
• ⁵³ Unité de recherche en santé des populations, Centre des maladies du sein Deschênes-Fabia, Centre de recherche FRSQ du Centre hospitalier affilié universitaire de Québec, Québec City, G1J 1Z4, Québec, Canada.
• ⁵⁴ Cancer Research Institute, Seoul National University, Seoul, 08826, Korea.
• ⁵⁵ Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Korea.
• ⁵⁶ Center for Medical Genetics, Ghent University, Ghent, 9000, Belgium.
• ⁵⁷ Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, 87131, New Mexico, USA.
• ⁵⁸ Department of Oncology, Sheffield Cancer Research, University of Sheffield, Sheffield, S10 2TN, UK.
• ⁵⁹ Harvard HT Chan School of Public Health, Boston, 02115, Massachusetts, USA.
• ⁶⁰ Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, 02115, Massachusetts, USA.
• ⁶¹ Department of Neuroscience, Academic Unit of Pathology, University of Sheffield, Sheffield, S10 2TN, UK.
• ⁶² Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, 70-115, Poland.
• ⁶³ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, SE-171 77, Sweden.
• ⁶⁴ Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, 19111, Pennsylvania, USA.
• ⁶⁵ INSERM U1052, CNRS UMR5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, 69373, France.
• ⁶⁶ Department of Pathology and Laboratory Diagnostics the Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, 44-101, Poland.
• ⁶⁷ Department of Pathology, Leiden University Medical Center, Leiden, 2333, The Netherlands.
• ⁶⁸ Department of Human Genetics, Leiden University Medical Center, Leiden, 2333, The Netherlands.
• ⁶⁹ Oncogenetics Group, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO) and Universitat Autònoma de Barcelona, Barcelona, 08035, Spain.
• ⁷⁰ Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, 03755, New Hampshire, USA.
• ⁷¹ Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 19104, Pennsylvania, USA.
• ⁷² Department of Genetics, University of Pretoria, Pretoria, 0083, South Africa.
• ⁷³ Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, G1V 4G2, Québec, Canada.
• ⁷⁴ Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, 751 05, Sweden.
• ⁷⁵ Department of Clinical Genetics, Lund University Hospital, Lund, 221 00, Sweden.
• ⁷⁶ Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, 2100, Denmark.
• ⁷⁷ Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, 04107, Germany.
• ⁷⁸ Genomic Medicine, Manchester Academic Health Sciences Centre, Institute of Human Development, Manchester University, Central Manchester University Hospitals NHS Foundation Trust, Manchester, M13 9PL, UK.
• ⁷⁹ Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, 90095, California, USA.
• ⁸⁰ Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute),Catalan Institute of Oncology, Barcelona, 08908, Spain.
• ⁸¹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, 20892, Maryland, USA.
• ⁸² Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
• ⁸³ Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
• ⁸⁴ Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK.
• ⁸⁵ Division of Breast Cancer Research, The Institute of Cancer Research, London, SW7 3RP, UK.
• ⁸⁶ Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, 2730, Denmark.
• ⁸⁷ Masaryk Memorial Cancer Institute and Medical Faculty MU, Brno, 625 00, Czech Republic.
• ⁸⁸ Molecular Diagnostics Laboratory, (INRASTES) Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, 153 10, Greece.
• ⁸⁹ Departments of Human Genetics and Oncology, Program in Cancer Genetics, McGill University, Montreal, Montreal, H2W 1S6, Quebec, Canada.
• ⁹⁰ Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, 66160, Kansas, USA.
• ⁹¹ Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, 52621, Israel.
• ⁹² Department of Laboratory Medicine, Section of Genetic Oncology, University and University Hospital of Pisa, Pisa, 56126, Italy.
• ⁹³ Division of Cancer Prevention & Control Research, UCLA Schools of Medicine and Public Health, Jonsson Comprehensive Cancer Center, Los Angeles, 90024, California, USA.
• ⁹⁴ Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, 02215, Massachusetts, USA.
• ⁹⁵ Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
• ⁹⁶ Women's Cancer, UCL EGA Institute for Women's Health, London, WC1E 6AU, UK.
• ⁹⁷ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, 3010, Victoria, Australia.
• ⁹⁸ Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, UK.
• ⁹⁹ Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, 66160, Kansas, USA.
• ¹⁰⁰ Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montreal, H3A 1A1, Québec, Canada.
• ¹⁰¹ Department of Medicine, McGill University, Montreal, H3A 1A1, Québec, Canada.
• ¹⁰² Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, 84132, Utah, USA.
• ¹⁰³ Department of Health Sciences Research, Mayo Clinic, Rochester, 55902, Minnesota, USA.
• ¹⁰⁴ Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, 90048, California, USA.
• ¹⁰⁵ Department of Biomedical Sciences, Community and Population Health Research Institute, Cedars-Sinai Medical Center, Los Angeles, 90048, California, USA.
• ¹⁰⁶ Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, National Institutes of Health, Rockville, 20892, Maryland, USA.
• ¹⁰⁷ Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, 70-204, Poland.
• ¹⁰⁸ Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, 94805, France.
• ¹⁰⁹ University Paris-Sud, Villejuif, 91405, France.
• ¹¹⁰ Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
• ¹¹¹ Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, 2100, Denmark.
• ¹¹² Department of Oncology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, CB1 8RN, UK.
• ¹¹³ Saw Swee Hock School of Public Health, National University of Singapore, Singapore, 119077, Singapore.
• ¹¹⁴ Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, 50603, Malaysia.
• ¹¹⁵ Cancer Research Initiatives Foundation, Subang Jaya, Selangor, 47500, Malaysia.
• ¹¹⁶ Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, 45136, Germany.
• ¹¹⁷ Department of Gynecology and Gynecologic Oncology, Dr Horst Schmidt Kliniken Wiesbaden, Wiesbaden, 65199, Germany.
• ¹¹⁸ Clinical Cancer Genetics, for the City of Hope Clinical Cancer Genetics Community Research Network, Duarte, 91010, California, USA.
• ¹¹⁹ Department of Pathology, Molecular Unit, Herlev Hospital, University of Copenhagen, Copenhagen, 2730, Denmark.
• ¹²⁰ Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, DK-2100, Denmark.
• ¹²¹ Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, 2100, Denmark.
• ¹²² Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, 1006, The Netherlands.
• ¹²³ Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, 3015, The Netherlands.
• ¹²⁴ Center for Medical Genetics, NorthShore University Health System, Evanston, 60201, Illinois, USA.
• ¹²⁵ N.N. Petrov Institute of Oncology, St Petersburg, 197758, Russia.
• ¹²⁶ Lombardi Comprehensive Cancer Center, Georgetown University, Washington, 20057, District of Columbia, USA.
• ¹²⁷ Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi, 464-8681, Japan.
• ¹²⁸ State Research Institute Centre for Innovative Medicine, Vilnius, LT-01102, Lithuania.
• ¹²⁹ Department of Epidemiology, Cancer Prevention Institute of California, Fremont, 94538, California, USA.
• ¹³⁰ Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, 08826, Korea.
• ¹³¹ Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, 3010, Victoria, Australia.
• ¹³² Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, 90048, California, USA.
• ¹³³ Radboud University Medical Centre, Radboud Institute for Health Sciences, Nijmegen, 6500, The Netherlands.
• ¹³⁴ Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, M5G 1X5, Ontario, Canada.
• ¹³⁵ Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, M5T 3M7, Ontario, Canada.
• ¹³⁶ Department of Clinical Pathology, Imaging Center, Kuopio University Hospital, Kuopio, 70210, Finland.
• ¹³⁷ Cancer Center, Kuopio University Hospital, Kuopio, 70210, Finland.
• ¹³⁸ Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, 70210, Finland.
• ¹³⁹ Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, 1478, Oslo, Norway.
• ¹⁴⁰ The Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, China.
• ¹⁴¹ Department of Surgery, The University of Hong Kong, Hong Kong, China.
• ¹⁴² Vesalius Research Center, VIB, Leuven, 3000, Belgium.
• ¹⁴³ Department of Oncology, Laboratory for Translational Genetics, University of Leuven, Leuven, 3000, Belgium.
• ¹⁴⁴ Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, SE-171 77, Sweden.
• ¹⁴⁵ Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, CV4 7AL, UK.
• ¹⁴⁶ Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA.
• ¹⁴⁷ Department of Preventive and Predictive Medicine, Unit of Medical Genetics, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, 20133, Italy.
• ¹⁴⁸ University of Hawaii Cancer Center, Honolulu, 96813, Hawaii, USA.
• ¹⁴⁹ Department of Oncology - Pathology, Karolinska Institutet, Stockholm, SE-171 77, Sweden.
• ¹⁵⁰ National Center for Tumour Diseases, University of Heidelberg, Heidelberg, 69117, Germany.
• ¹⁵¹ Department of Gynaecology, Radboud University Medical Centre, Nijmegen, 6500, The Netherlands.
• ¹⁵² Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, 812-8582, Japan.
• ¹⁵³ Anatomical Pathology, The Alfred Hospital, Melbourne, 3004, Victoria, Australia.
• ¹⁵⁴ Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, G61 1BD, UK.
• ¹⁵⁵ Division of Gynaecology and Obstetrics, Technische Universität München, Munich, 81675, Germany.
• ¹⁵⁶ Department of Human Genetics, Radboud University Medical Centre, Nijmegen, 6500, The Netherlands.
• ¹⁵⁷ Immunology and Molecular Oncology Unit, Instituto Oncologico Veneto IOV, IRCCS, Padua, 35128, Italy.
• ¹⁵⁸ Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, 14263, New York, USA.
• ¹⁵⁹ Institute of Population Health, University of Manchester, Manchester, M13 9PL, UK.
• ¹⁶⁰ Laboratory Medicine Program, University Health Network, Toronto, M5G 1L7, Ontario, Canada.
• ¹⁶¹ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, M5G 1L7, Ontario, Canada.
• ¹⁶² The University of Texas School of Public Health, Houston, 77030, Texas, USA.
• ¹⁶³ Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, 91010, California, USA.
• ¹⁶⁴ Department of Medicine and Genetics, University of California, San Francisco, 94143, California, USA.
• ¹⁶⁵ Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, 14263, New York, USA.
• ¹⁶⁶ Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, 10065, USA.
• ¹⁶⁷ Department of Molecular Genetics, National Institute of Oncology, Budapest, 1122, Hungary.
• ¹⁶⁸ Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, 60637, Illinois, USA.
• ¹⁶⁹ The Ohio State University and the James Cancer Center, Columbus, 43210, Ohio, USA.
• ¹⁷⁰ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, 10017, USA.
• ¹⁷¹ Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, 28019, Spain.
• ¹⁷² Biomedical Network on Rare Diseases (CIBERER), Madrid, 28029, Spain.
• ¹⁷³ Department of Surgery, Seoul National University College of Medicine, Seoul, 03080, Korea.
• ¹⁷⁴ Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, 97239, Oregon, USA.
• ¹⁷⁵ Knight Cancer Institute, Oregon Health and Science University, Portland, 97239, Oregon, USA.
• ¹⁷⁶ IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, 16 20139, Italy.
• ¹⁷⁷ Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
• ¹⁷⁸ Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, 33606, Florida, USA.
• ¹⁷⁹ Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, 02115, Massachusetts, USA.
• ¹⁸⁰ Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, 02115, Massachusetts, USA.
• ¹⁸¹ Laboratory of Cancer Genetics and Tumour Biology, Northern Finland Laboratory Centre NordLab, Oulu, FI-90014, Finland.
• ¹⁸² Department of Clinical Chemistry and Biocenter Oulu, Laboratory of Cancer Genetics and Tumour Biology, University of Oulu, Oulu, FI-90014, Finland.
• ¹⁸³ Department of Preventive and Predictive Medicine, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, 20133, Italy.
• ¹⁸⁴ Department of Clinical Genetics, Karolinska University Hospital, Stockholm, 171 76, Sweden.
• ¹⁸⁵ Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, 54000, Pakistan.
• ¹⁸⁶ Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, 34362, Israel.
• ¹⁸⁷ Department of Gynaecology and Obstetrics and Centre for Integrated Oncology (CIO), Centre of Familial Breast and Ovarian Cancer, Center for Molecular Medicine Cologne (CMMC), University Hospital of Cologne, Cologne, 50931, Germany.
• ¹⁸⁸ Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, 06510, Connecticut, USA.
• ¹⁸⁹ Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, 60201, Illinois, USA.
• ¹⁹⁰ Division of Public Health Sciences, Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, 98109, Washington, USA.
• ¹⁹¹ Department of Epidemiology, University of Washington, Seattle, 98109, Washington, USA.
• ¹⁹² National Cancer Institute, Bangkok, 10400, Thailand.
• ¹⁹³ Research Oncology, Guy's Hospital, King's College London, London, SE1 9RT, UK.
• ¹⁹⁴ Department of Community and Family Medicine, Duke University Medical Center, Durham, 27710, North Carolina, USA.
• ¹⁹⁵ Cancer Control and Population Sciences, Duke Cancer Institute, Durham, 27710, North Carolina, USA.
• ¹⁹⁶ Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, 1066 CX, The Netherlands.
• ¹⁹⁷ Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, 50676, Germany.
• ¹⁹⁸ Center for Integrated Oncology, University Hospital of Cologne, Cologne, 50676, Germany.
• ¹⁹⁹ Center for Molecular Medicine, University Hospital of Cologne, Cologne, 50676, Germany.
• ²⁰⁰ Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, 50676, Germany.
• ²⁰¹ Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, 115, Taiwan.
• ²⁰² School of Public Health, China Medical University, Taichung, 404, Taiwan.
• ²⁰³ Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, 94305, California, USA.
• ²⁰⁴ Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, 69008, France.
• ²⁰⁵ INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, 69003, France.
• ²⁰⁶ Department of Pathology, University of Melbourne, Parkville, 3010, Victoria, Australia.
• ²⁰⁷ Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, 581 83, Sweden.
• ²⁰⁸ Institut Curie, Department of Tumour Biology, Paris, France; Department of Tumour Biology, Institut Curie, Paris, France.
• ²⁰⁹ Institut Curie, INSERM U830, Paris, 75248, France.
• ²¹⁰ Université Paris Descartes, Sorbonne Paris Cité, Paris, 75270, France.
• ²¹¹ Department of Human Genetics, Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, 69120, Germany.
• ²¹² Department of Genetics, Portuguese Oncology Institute, Porto, 4200-072, Portugal.
• ²¹³ Biomedical Sciences Institute (ICBAS), Porto University, Porto, 4099-002, Portugal.
• ²¹⁴ Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, 10027, USA.
• ²¹⁵ Department of Clinical Genetics, Odense University Hospital, Odense C, 5000, Denmark.
• ²¹⁶ UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, 21100, Italy.
• ²¹⁷ Latvian Biomedical Research and Study Centre, Riga, LV-1067, Latvia, Sweden.
• ²¹⁸ Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico), Padua, 64 - 35128, Italy.
• ²¹⁹ Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, 43210, Ohio, USA.
• ²²⁰ Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, OX3 7BN, UK.
• ²²¹ Institute of Human Genetics, Pontificia Universidad Javeriana, Cra. 7 #40-62, Bogota, Colombia.
• ²²² Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, 02215, Massachusetts, USA.
• ²²³ Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, 3015 CE, The Netherlands.
• ²²⁴ Department of Gynecology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, 3015 CE, The Netherlands.
• ²²⁵ Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Leuven, B-3000, Belgium.
• ²²⁶ University Hospital Ulm, Ulm, 89069, Germany.
• ²²⁷ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, 20892, Maryland, USA.
• ²²⁸ Department of General Medical Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, B-3000, Belgium.
• ²²⁹ Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Athens, 153 10, Greece.
• ²³⁰ Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, 47500, Malaysia.
• ²³¹ University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, 59100, Malaysia.
• ²³² Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114, Taiwan.
• ²³³ Shanghai Center for Disease Control and Prevention, Shanghai, China.
• ²³⁴ Division of Population Sciences, Cancer Epidemiology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, 33612, Florida, USA.
• ²³⁵ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, 55905, Minnesota, USA.
• ²³⁶ Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK. aca20@medschl.cam.ac.uk.
• ²³⁷ The Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.